Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01614015 · ClinicalTrials.gov registry record · Phase 2

Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial

A Phase 2 study of Substance Abuse and Delinquency, sponsored by Oregon Research Institute.

Completed
Registry status
Phase 2
Development phase
328
Enrollment target
1
Study location

NCT01614015 is a Phase 2 study of Substance Abuse and Delinquency that has completed, run by Oregon Research Institute. The registered enrollment target is 328 participants, below the 5,254-participant average among 58 other Substance Abuse trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01614015, a Phase 2 study of Substance Abuse and Delinquency, has completed, sponsored by Oregon Research Institute.

COMPLETED
Registry status
Phase 2
Development phase
328 participants
Enrollment target
1
Study location

Study Summary

The proposed effectiveness study examines differences in treatment outcomes of an observation-based supervision (BOOST) versus supervision as usual (SAU). The study will be implemented within 16 teams delivering FFT services at 11 sites in the California Institute of Mental Health (CIMH) system. The 16 FFT therapist teams will be randomly assigned either to BOOST or SAU. Each team will have 3 therapists who will treat 6 families for a total of 18 families per team. Thus, each condition will include 24 therapists who will treat 144 families. The project will be implemented in four staggered waves to establish a more even rate of data collection and treatment implementation to enhance the feasibility of the study by keeping staffing and project costs more constant across the 5-year project. Each wave will involve 4 FFT teams, 2 receiving BOOST and 2 receiving SAU. Teams will be randomized to supervision conditions. Outcome assessments of parents and adolescents will be conducted at baseline and at 4 months and 16 months after treatment initiation.

Conditions Studied

Substance Abuse Delinquency Self Destructive Behavior

Interventions

  • BEHAVIORAL Supervision
  • BEHAVIORAL Observational Supervision

Study Locations (1)

Oregon

  • Oregon Research Institute - Eugene

Trial Details

FieldValue
Enrollment Target 328 participants
Start Date 2010-09
Est. Completion 2016-06
Phase Phase 2

Sponsor

Oregon Research Institute

62 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01614015

The ClinicalTrials.gov registry entry for NCT01614015 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 328 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,254-participant average among 58 other Substance Abuse trials with a reported enrollment target (94% lower). The listed sponsor is Oregon Research Institute, which has 62 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Substance Abuse appearing as the primary indexed condition, and to 2 interventions - of which Supervision is the first listed.

NCT01614015 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT01614015 about?

NCT01614015 is a clinical study titled "Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial". The proposed effectiveness study examines differences in treatment outcomes of an observation-based supervision (BOOST) versus supervision as usual (SAU). The study will be implemented within 16 teams delivering FFT services at 11 sites in the California Institute of Mental Health (CIMH) system. The...

What is the current status of trial NCT01614015?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 328 participants. The study started on 2010-09. Estimated completion is 2016-06.

What conditions does trial NCT01614015 study?

This clinical trial studies the following conditions: Substance Abuse, Delinquency, Self Destructive Behavior.

What interventions are being tested in trial NCT01614015?

The interventions under investigation include: Supervision (BEHAVIORAL), Observational Supervision (BEHAVIORAL).

Who is sponsoring clinical trial NCT01614015?

This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01614015 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Substance Abuse

All registered trials for this condition

Delinquency

All registered trials for this condition

Oregon

All trials with a study site in Oregon

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.